Bioregenx (BRGX) Liabilities and Shareholders Equity (2021 - 2026)
Bioregenx (BRGX) recorded quarterly Liabilities and Shareholders Equity of $337070.0 in Q1 2026, down 17.99% quarter-over-quarter from $410986.0 in Q4 2025, and down 30.16% on a YoY basis from $482623.0 in Q1 2025.
Bioregenx (BRGX) Liabilities and Shareholders Equity (2021 - 2026) Analysis & Trends
Bioregenx's Liabilities and Shareholders Equity history runs 6 years deep, the most recent figure standing at $337070.0 for Q1 2026.
- In Q1 2026, Liabilities and Shareholders Equity fell 30.16% year-over-year to $337070.0; the TTM figure through Mar 2026 stood at $3.1 million (down 91.54% YoY), while the FY2025 annual figure was $410986.0, down 19.18% from the prior year.
- Liabilities and Shareholders Equity was $337070.0 for Q1 2026 at Bioregenx, down from $410986.0 in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $18.6 million in Q1 2024 to a low of $33981.0 in Q3 2023.
- Historically, Liabilities and Shareholders Equity has averaged $4.2 million across 5 years, with a median of $495579.0 in 2024.
- The sharpest annual moves came in 2024 and 2025: Liabilities and Shareholders Equity surged 50991.39% in 2024, then plunged 97.41% in 2025.
- A 5-year view of Liabilities and Shareholders Equity shows it stood at $59149.0 in 2022, then jumped by 1363.68% to $865750.0 in 2023, then sank by 41.26% to $508535.0 in 2024, then declined by 19.18% to $410986.0 in 2025, then decreased by 17.99% to $337070.0 in 2026.
- The last three Liabilities and Shareholders Equity figures came in at $337070.0 (Q1 2026), $410986.0 (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn | 9.13 Bn |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn | 6.21 Bn |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn | 3.31 Bn |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn | 728.77 Mn |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn | 1.02 Bn |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn | 1.12 Bn |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn | 5.84 Bn |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn | 1.42 Bn |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn | 2.00 Bn |
| 10 | Bioregenx | - | - | 348,288.00 | 337,070.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 337,070.00 |
| Dec 31, 2025 | 410,986.00 |
| Sep 30, 2025 | 1.17 Mn |
| Jun 30, 2025 | 1.15 Mn |
| Mar 31, 2025 | 482,623.00 |
| Dec 31, 2024 | 508,535.00 |
| Sep 30, 2024 | 17.36 Mn |
| Jun 30, 2024 | 17.89 Mn |
| Mar 31, 2024 | 18.62 Mn |
| Dec 31, 2023 | 865,750.00 |
| Sep 30, 2023 | 33,981.00 |
| Jun 30, 2023 | 85,506.00 |
| Mar 31, 2023 | 77,989.00 |
| Dec 31, 2022 | 59,149.00 |
| Dec 31, 2021 | 127,762.00 |